AC Immune SA reported earnings results for the first quarter ended March 31, 2026. For the first quarter, the company reported revenue was CHF 1.12 million compared to CHF 0.99 million a year ago. Net loss was CHF 14.8 million compared to CHF 19.03 million a year ago.

Basic loss per share from continuing operations was CHF 0.15 compared to CHF 0.19 a year ago.